Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Gregg Smith"'
Autor:
Gallegos, CRR1 (AUTHOR), Gregg-Smith, SJ1 (AUTHOR), Ashworth, C1 (AUTHOR), Courtney, E1 (AUTHOR)
Publikováno v:
Bulletin of The Royal College of Surgeons of England. Jun2023, Vol. 105 Issue 4, p203-207. 5p.
Autor:
Sri Keerthana Gopikrishnan, David Gregg Smith Ponraj, Ariarathinam Newtonraj, Anil Jacob Purty, Mani Manikandan, Antony Vincent
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 9, Iss 8, Pp 4333-4336 (2020)
Introduction: Alcohol use is a major public health problem in India. We sought to study the use of alcohol and its risk factors in a rural area in South India. Methods: This study was conducted in 20 villages surrounding a Rural Health Training Centr
Externí odkaz:
https://doaj.org/article/d09e47b50db94fed8cf75d2a5fee5ea4
Autor:
David Gregg Smith Ponraj, Sri Keerthana Gopikrishnan, Ariarathinam Newtonraj, Mark Christopher Arokiaraj, Anil Jacob Purty, Sunil Kumar Nanda, Mani Manikandan, Antony Vincent
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 9, Iss 8, Pp 4145-4150 (2020)
Introduction: Cardiovascular diseases (CVDs) are major problems in India and many other developing and developed countries. As India is committed to provide universal health care for the population, there is a need to find out the prevalence and dete
Externí odkaz:
https://doaj.org/article/b07a846db29541ed97794622d1040f2b
Publikováno v:
The Bulletin of the Royal College of Surgeons of England. 105:203-207
Autor:
Dallas Snider, Brandy E. Strahan, Jessica L Ryan, Maureen W. Howard, Rebecca McClain, Debra M. Vinci, Gregg Smith
Publikováno v:
Journal of Community Health. 47:53-62
Public acceptance of the HPV vaccine has not matched that of other common adolescent vaccines, and HPV vaccination rates remain below the Healthy People 2020 target of 80% compliance. The purpose of this study was to evaluate the capacity of nine ped
Autor:
Sunil Kumar Nanda, Sri Keerthana Gopikrishnan, Ariarathinam Newtonraj, David Gregg Smith Ponraj, Antony Vincent, M. Manikandan, Anil J Purty, Mark Christopher Arokiaraj
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 9, Iss 8, Pp 4145-4150 (2020)
Journal of Family Medicine and Primary Care
Journal of Family Medicine and Primary Care
Introduction: Cardiovascular diseases (CVDs) are major problems in India and many other developing and developed countries. As India is committed to provide universal health care for the population, there is a need to find out the prevalence and dete
Autor:
Gregg Smith
We investigate the 2020 Presidential Election by using the county as the unit of analysis (n= 3,112) and examine the variance in the county percentage of votes cast for Biden and Trump as dependent variables. Our seven independent variables are conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75b7c93fe9262ffa8c0d9f77b17be3ff
https://doi.org/10.33774/apsa-2021-m2h51
https://doi.org/10.33774/apsa-2021-m2h51
Autor:
Gregg Smith, Jazmin Young
We investigate the 2016 Presidential Election using the county as the unit of analysis to examine the variance in the percentage of votes cast for Clinton, Trump and voter turnout. Our independent variables conceptually relate to race, education, wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60054fa2c52a03c7d35aa1e62b3c7034
https://doi.org/10.31124/advance.12751913
https://doi.org/10.31124/advance.12751913
Autor:
Veena G Jones, Dominick L. Frosch, Cheryl D Stults, Hari Krishnan, Jiang Li, Gregg Smith-McCurdy, Albert S. Chan
Publikováno v:
JAMA Network Open
This quality improvement study examines the accuracy and user experience of a cost estimator tool delivered via an online patient portal and informed by real-time data from third-party payers.
Key Points Question Can a cost estimation tool provi
Key Points Question Can a cost estimation tool provi
Autor:
Stephen T. Oh, Blanca Xicoy, Daniel El Fassi, Marianne Tang Severinsen, Tomasz Sacha, Srdan Verstovsek, Miklos Egyed, Mary Frances McMullin, Bjorn Andreasson, Doroteya K. Todorieva-Todorova, Francesco Passamonti, Ewa Lech-Marańda, Mark Kowalski, Gregg Smith, Donal P. McLornan, Claire N. Harrison, Viviane Dubruille, Christof Scheid, Ruben A. Mesa
Publikováno v:
Blood. 136:51-52
Introduction: Momelotinib (MMB) is a potent JAK1, JAK2 and ACVR1 inhibitor with clinical activity against the three hallmark features of myelofibrosis (MF), namely anemia, constitutional symptoms and splenomegaly, across the continuum of intermediate